RSS Feed
UCLB has been working closely with Professor Kerry Chester and her colleagues from the UCL Cancer Institute to support the development of new humanised antibodies with potential to treat cancer. In a collaboration enabled by UCLB, Professor Chester will work with scientists from the... more
Scientists funded by the Medical Research Council have successfully used adult human retinal stem cells to repair nerve cells damaged in glaucoma, partially restoring vision in rats. If the success can be replicated in humans it may eventually lead to new treatments for glaucoma, the... more
The award - given as part of the Science Business Academic Excellence Awards (ACES) - was to recognise Endomagnetics as one of the most promising European university life sciences spin-out companies and was announced at the European Entrepreneurship Summit in Brussels on Tuesday.... more
The Carbon Trust is injecting over half a million pounds into a collaboration between UCL and Imperial College to accelerate the commercialisation of an innovative fuel cell. The new technology could help the UK gain a significant share of a fuel cell market estimated by the Carbon... more
Abcodia, a biomarker validation company and a UCL spin out company, with investment from UCLB, has today announced a collaboration with life sciences company Volition Rx which will advance the development of biomarkers for the early detection of cancer. The partnership will discover... more
Researchers at UCL have made a significant advance towards developing a treatment for Corneal Surface Disease, using RAFTTM; a UCLB patented technology licensed to Tap Biosystems. The development was led by Professor Robert Brown at UCL's Tissue Repair and Engineering Centre (TREC)... more
The Orion fund is being launched in a partnership between UCLB, MTI and the technology transfer offices of the Universities of Manchester and Edinburgh. UCLB will work alongside UMI3 of the University of Manchester and ERI from the University of Edinburgh to identify investment... more
The competition, hosted by Ernst & Young at its London headquarters, saw the eight teams of students selected by the UCL Entrepreneurs Society battling it out in a series of challenges to be crowned ultimate victor. The day saw the teams in a frantic dash around London completing... more
UCLB 2011 Award winner, Professor Sir Mark Pepys was knighted for services to Biomedicine in this year's New Years Honour 2012 list. Professor Pepys is the founder of Pentraxin Therapeutics Ltd, a UCL spinout company which focuses on the treatment of amyloidosis and the Director of the... more
The ACES (Academic Enterprise Awards) programme, formed to promote innovation in Europe, is holding its fourth annual awards final in Brussels next year. Selected as one of three finalists in the Life Sciences award category, Endomagnetics Ltd is to participate in the two day "Start up! The... more
